Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients

(2015) Xia-Ying Kuang et al.   Oncotarget

PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways

(2014) Xueqiong Fu et al.   BIOSCIENCE REPORTS

The relationships between the immunoexpression of KAI1, MMP-2, MMP-9 and steroid receptors expression in endometrial cancer

(2014) Anna Grybos et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

SHARP1 Suppresses Angiogenesis of Endometrial Cancer by Decreasing Hypoxia-Inducible Factor-1α Level

(2014) Yun Liao et al.   PLoS One

Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling

(2014) Simon Schimmack et al.   TUMOR BIOLOGY

High Phospho-Stathmin(Serine38) Expression Identifies Aggressive Endometrial Cancer and Suggests an Association with PI3K Inhibition

(2013) E. Wik et al.   CLINICAL CANCER RESEARCH

Markers for individualised therapy in endometrial carcinoma

(2012) Helga B Salvesen et al.   LANCET ONCOLOGY

Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer

(2011) J. Trovik et al.   CLINICAL CANCER RESEARCH

Stathmin is involved in arsenic trioxide-induced apoptosis in human cervical cancer cell lines via PI3K linked signal pathway

(2010) Xi Wang et al.   CANCER BIOLOGY & THERAPY

Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis

(2010) Si-Guang Xu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

(2009) H. B. Salvesen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Stathmin 1: a novel therapeutic target for anticancer activity

(2008) Shushan Rana et al.   Expert Review of Anticancer Therapy